|
Fusion gene ID: 2617 |
FusionGeneSummary for ARID1A_TFPI |
Fusion gene summary |
Fusion gene information | Fusion gene name: ARID1A_TFPI | Fusion gene ID: 2617 | Hgene | Tgene | Gene symbol | ARID1A | TFPI | Gene ID | 8289 | 7035 |
Gene name | AT-rich interaction domain 1A | tissue factor pathway inhibitor | |
Synonyms | B120|BAF250|BAF250a|BM029|C1orf4|CSS2|ELD|MRD14|OSA1|P270|SMARCF1|hELD|hOSA1 | EPI|LACI|TFI|TFPI1 | |
Cytomap | 1p36.11 | 2q32.1 | |
Type of gene | protein-coding | protein-coding | |
Description | AT-rich interactive domain-containing protein 1AARID domain-containing protein 1AAT rich interactive domain 1A (SWI-like)BRG1-associated factor 250aOSA1 nuclear proteinSWI-like proteinSWI/SNF complex protein p270SWI/SNF-related, matrix-associated, | tissue factor pathway inhibitoranti-convertinextrinsic pathway inhibitortissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) | |
Modification date | 20180519 | 20180523 | |
UniProtAcc | O14497 | P10646 | |
Ensembl transtripts involved in fusion gene | ENST00000324856, ENST00000457599, ENST00000374152, ENST00000540690, | ENST00000392365, ENST00000233156, ENST00000409676, ENST00000339091, | |
Fusion gene scores | * DoF score | 21 X 13 X 13=3549 | 4 X 4 X 3=48 |
# samples | 31 | 4 | |
** MAII score | log2(31/3549*10)=-3.51707245378671 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/48*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: ARID1A [Title/Abstract] AND TFPI [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ARID1A | GO:0006337 | nucleosome disassembly | 8895581 |
Hgene | ARID1A | GO:0006338 | chromatin remodeling | 11726552 |
Hgene | ARID1A | GO:0030520 | intracellular estrogen receptor signaling pathway | 12200431 |
Hgene | ARID1A | GO:0030521 | androgen receptor signaling pathway | 12200431 |
Hgene | ARID1A | GO:0042921 | glucocorticoid receptor signaling pathway | 12200431 |
Hgene | ARID1A | GO:0045893 | positive regulation of transcription, DNA-templated | 12200431 |
Tgene | TFPI | GO:0030195 | negative regulation of blood coagulation | 21868574 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | CK300697 | ARID1A | chr1 | 27108477 | - | TFPI | chr2 | 188369030 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
3UTR-intron | ENST00000324856 | ENST00000392365 | ARID1A | chr1 | 27108477 | - | TFPI | chr2 | 188369030 | + |
3UTR-intron | ENST00000324856 | ENST00000233156 | ARID1A | chr1 | 27108477 | - | TFPI | chr2 | 188369030 | + |
3UTR-intron | ENST00000324856 | ENST00000409676 | ARID1A | chr1 | 27108477 | - | TFPI | chr2 | 188369030 | + |
3UTR-intron | ENST00000324856 | ENST00000339091 | ARID1A | chr1 | 27108477 | - | TFPI | chr2 | 188369030 | + |
intron-intron | ENST00000457599 | ENST00000392365 | ARID1A | chr1 | 27108477 | - | TFPI | chr2 | 188369030 | + |
intron-intron | ENST00000457599 | ENST00000233156 | ARID1A | chr1 | 27108477 | - | TFPI | chr2 | 188369030 | + |
intron-intron | ENST00000457599 | ENST00000409676 | ARID1A | chr1 | 27108477 | - | TFPI | chr2 | 188369030 | + |
intron-intron | ENST00000457599 | ENST00000339091 | ARID1A | chr1 | 27108477 | - | TFPI | chr2 | 188369030 | + |
intron-intron | ENST00000374152 | ENST00000392365 | ARID1A | chr1 | 27108477 | - | TFPI | chr2 | 188369030 | + |
intron-intron | ENST00000374152 | ENST00000233156 | ARID1A | chr1 | 27108477 | - | TFPI | chr2 | 188369030 | + |
intron-intron | ENST00000374152 | ENST00000409676 | ARID1A | chr1 | 27108477 | - | TFPI | chr2 | 188369030 | + |
intron-intron | ENST00000374152 | ENST00000339091 | ARID1A | chr1 | 27108477 | - | TFPI | chr2 | 188369030 | + |
intron-intron | ENST00000540690 | ENST00000392365 | ARID1A | chr1 | 27108477 | - | TFPI | chr2 | 188369030 | + |
intron-intron | ENST00000540690 | ENST00000233156 | ARID1A | chr1 | 27108477 | - | TFPI | chr2 | 188369030 | + |
intron-intron | ENST00000540690 | ENST00000409676 | ARID1A | chr1 | 27108477 | - | TFPI | chr2 | 188369030 | + |
intron-intron | ENST00000540690 | ENST00000339091 | ARID1A | chr1 | 27108477 | - | TFPI | chr2 | 188369030 | + |
Top |
FusionProtFeatures for ARID1A_TFPI |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
ARID1A | TFPI |
Inhibits factor X (X(a)) directly and, in a Xa-dependentway, inhibits VIIa/tissue factor activity, presumably by forming aquaternary Xa/LACI/VIIa/TF complex. It possesses an antithromboticaction and also the ability to associate with lipoproteins inplasma. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for ARID1A_TFPI |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for ARID1A_TFPI |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for ARID1A_TFPI |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | TFPI | P10646 | DB00036 | Coagulation factor VIIa Recombinant Human | Tissue factor pathway inhibitor | biotech | approved |
Tgene | TFPI | P10646 | DB06779 | Dalteparin | Tissue factor pathway inhibitor | small molecule | approved |
Top |
RelatedDiseases for ARID1A_TFPI |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | ARID1A | C0038356 | Stomach Neoplasms | 3 | CTD_human |
Hgene | ARID1A | C2239176 | Liver carcinoma | 3 | CTD_human |
Hgene | ARID1A | C0001418 | Adenocarcinoma | 1 | CTD_human |
Hgene | ARID1A | C0005695 | Bladder Neoplasm | 1 | CTD_human |
Hgene | ARID1A | C0006413 | Burkitt Lymphoma | 1 | CTD_human |
Hgene | ARID1A | C0007138 | Carcinoma, Transitional Cell | 1 | CTD_human |
Hgene | ARID1A | C0010606 | Adenoid Cystic Carcinoma | 1 | CTD_human |
Hgene | ARID1A | C0014170 | Endometrial Neoplasms | 1 | CTD_human |
Hgene | ARID1A | C0027819 | Neuroblastoma | 1 | CTD_human |
Hgene | ARID1A | C0036920 | Sezary Syndrome | 1 | CTD_human |
Hgene | ARID1A | C0079772 | T-Cell Lymphoma | 1 | CTD_human |
Hgene | ARID1A | C0079773 | Lymphoma, T-Cell, Cutaneous | 1 | CTD_human |
Hgene | ARID1A | C0206698 | Cholangiocarcinoma | 1 | CTD_human |
Hgene | ARID1A | C0265338 | Coffin-Siris syndrome | 1 | CTD_human;ORPHANET |
Hgene | ARID1A | C0279628 | Adenocarcinoma Of Esophagus | 1 | CTD_human |
Hgene | ARID1A | C0920269 | Microsatellite Instability | 1 | CTD_human |
Hgene | ARID1A | C2931822 | Nasopharyngeal carcinoma | 1 | CTD_human |
Tgene | TFPI | C0001883 | Airway Obstruction | 1 | CTD_human |
Tgene | TFPI | C0034155 | Purpura, Thrombotic Thrombocytopenic | 1 | CTD_human |
Tgene | TFPI | C0042487 | Venous Thrombosis | 1 | CTD_human |
Tgene | TFPI | C0242184 | Hypoxia | 1 | CTD_human |
Tgene | TFPI | C0600433 | Activated Protein C Resistance | 1 | CTD_human |
Tgene | TFPI | C3495559 | Juvenile arthritis | 1 | CTD_human |